P1.03-20 the Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.701
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Corrigendum: Blocking C-Met–mediated PARP1 Phosphorylation Enhances Anti-Tumor Effects of PARP Inhibitors

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Beta‐blockers Exert Potent Anti‐tumor Effects in Cutaneous and Uveal Melanoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Synthesis of Novel Sulfonamide-Based Calpain Inhibitors and Their Potential as Anti-Tumor Agents

English

Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-Hpv16 E7 Oncoprotein Monoclonal Antibodies

Viruses
VirologyInfectious Diseases
2020English

Bazedoxifene Enhances the Anti-Tumor Effects of Cisplatin and Radiation Treatment by Blocking IL-6 Signaling in Head and Neck Cancer

Oncotarget
Oncology
2016English

Soy Isoflavones Exert Beneficial Effects on Letrozole-Induced Rat Polycystic Ovary Syndrome (PCOS) Model Through Anti-Androgenic Mechanism

Pharmaceutical Biology
Molecular MedicinePharmacologyComplementaryAlternative MedicinePharmaceutical ScienceMedicineDrug Discovery
2016English

Beta-Endorphin - Novel Anti-Tumor Activity

Madridge Journal of Oncogenesis
2019English

P2.06-20 Bacteria as Novel Anti-Mesothelioma Agents.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Evaluation of Molecular Inhibitors of the C-Myc Oncoprotein

2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy